Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats

Psychopharmacology

Volumn 220, Issue 3, 2012, Pages 565-576

  Harris, Andrew C ^a,b   Stepanov, Irina ^c   Pentel, Paul R ^a,b,d   LeSage, Mark G ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Extract; Intracranial self stimulation; Locomotor sensitization; Nicotine; Nicotine discrimination; Non nicotine tobacco constituents; Smokeless tobacco

Indexed keywords

ALKALOID; ANABASINE; ANATABINE; NATURAL PRODUCT; NICOTINE; NORNICOTINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; HABITUATION; LATENT PERIOD; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SALIVA LEVEL; SELF STIMULATION; SENSITIZATION; SMOKELESS TOBACCO; SMOKING HABIT; STIMULUS RESPONSE; TOBACCO DEPENDENCE;

ALKALOIDS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISCRIMINATION LEARNING; DISEASE MODELS, ANIMAL; MALE; MOTOR ACTIVITY; NICOTINE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TISSUE DISTRIBUTION; TOBACCO USE DISORDER; TOBACCO, SMOKELESS;

EID: 84858439585     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2514-y     Document Type: Article

References (79)

1. Agatsuma S, Lee M, Zhu H, Chen K, Shih JC, Seif I, Hiroi N (2006) Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol Genet 15:2721-2731 (Pubitemid 44400399)
2. Ambrose V, Miller JH, Dickson SJ, Hampton S, Truman P, Lea RA, Fowles J (2007) Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells. Nicotine Tob Res 9:793-799 (Pubitemid 47190147)
3. Bardo MT, Green TA, Crooks PA, Dwoskin LP (1999) Nornicotine is self-administered intravenously by rats. Psychopharmacology (Berl) 146:290-296 (Pubitemid 29480240)
4. Battig K (1970) Differential effects of nicotine and tobacco smoke alkaloids on swimming endurance in the rat. Psychopharmaco-logia 18:300-304
5. Bauco P, Wise RA (1994) Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther 271:294-301 (Pubitemid 24333142)
6. Belluzzi JD, Wang R, Leslie FM (2005) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30:705-712 (Pubitemid 40397076)
7. Benowitz NL (2008) Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83:531-541 (Pubitemid 351417076)
8. Benowitz NL, Herrera B, Jacob P 3rd (2004) Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther 310:1208-1215 (Pubitemid 39108943)
9. Caggiula AR, Donny EC, Palmatier MI, Liu X, Chaudhri N, Sved AF (2009) The role of nicotine in smoking: a dual-reinforcement model. Nebr Symp Motiv 55:91-109
10. Cao J, Belluzzi JD, Loughlin SE, Keyler DE, Pentel PR, Leslie FM (2007) Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats. Neuropsychopharmacology 32:2025-2035 (Pubitemid 47258520)
11. Carr LA, Basham JK (1991) Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain. Life Sci 48:1173-1177
12. Carr LA, Basham JK, York BK, Rowell PP (1992) Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components. Eur J Pharmacol 215:285-287
13. Chan WS, Chowdhry S, Chang T, Kew RR (1999) Initial characterization of the complement activating compounds in extracts of smokeless tobacco. Immunobiology 201:64-73 (Pubitemid 29457301)
14. Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF (2006) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) 184:353-366 (Pubitemid 43255852)
15. Chou CC, Que Hee SS (1994) Bioassay-driven analysis of chewing tobacco extracts. Environ Toxicol Chem 13:1177-1186 (Pubitemid 24195335)
16. Clarke PBS, Kumar R (1983) The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 78:329-337 (Pubitemid 13192204)
17. Clemens KJ, Caille S, Stinus L, Cador M (2009) The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol: 1-12
18. Crooks PA, Dwoskin LP (1997) Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem Pharmacol 54:743-753 (Pubitemid 27404675)
19. Demady DR, Lowe ER, Everett AC, Billecke SS, Kamada Y, Dunbar AY, Osawa Y (2003) Metabolism-based inactivation of neuronal nitric-oxide synthase by components of cigarette and cigarette smoke. Drug Metabol Dispos 31:932-937 (Pubitemid 36759064)
20. DiFranza JR, Wellman RJ (2007) Sensitization to nicotine: how the animal literature might inform future human research. Nicotine Tob Res 9:9-20 (Pubitemid 47009040)
21. Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA, Clements LA, Sved AF (2003) Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl) 169:68-76 (Pubitemid 37088616)
22. Driscoll P, Battig K (1970) The effect of nicotine and total alkaloids extracted from cigarette smoke on avoidance behavior in rats under extinction procedure. Psychopharmaco-logia 18:305-313
23. Dwoskin LP, Crooks PA, Teng L, Green TA, Bardo MT (1999) Acute and chronic effects of nornicotine on locomotor activity in rats: altered response to nicotine. Psychopharmacology (Berl) 145:442-451 (Pubitemid 29424540)
24. Foddai M, Dosia G, Spiga S, Diana M (2004) Acetaldehyde increases dopaminergic neuronal activity in the VTA. Neuropsychophar-macology 29:530-536 (Pubitemid 38365929)
25. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ (2011) Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471:597-601
26. Ghosheh O, Dwoskin LP, Li WK, Crooks PA (1999) Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-(14)C]nicotine. Drug Metab Dispos 27:1448-1455
27. Goldberg SR, Risner ME, Stolerman IP, Reavill C, Garcha HS (1989) Nicotine and some related compounds: effects on schedule-controlled behaviour and discriminative properties in rats. Psychopharmacology (Berl) 97:295-302 (Pubitemid 19103419)
28. Green TA, Cain ME, Thompson M, Bardo MT (2003) Environmental enrichment decreases nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) 170:235-241 (Pubitemid 37491602)
29. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25:8593-8600 (Pubitemid 41362035)
30. Harris AC, Mattson C, Lesage MG, Keyler DE, Pentel PR (2010) Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats. Pharmacol Biochem Behav 96:217-227
31. Harris AC, Pentel PR, Burroughs D, Staley MD, Lesage MG (2011) A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats. Psychopharmacology (Berl), in press
32. Harrison AA, Gasparini F, Markou A (2002) Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychophar-macology (Berl) 160:56-66 (Pubitemid 34169826)
33. Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS (2007) Changing smokeless tobacco products new tobacco-delivery systems. Am J Prev Med 33:S368-S378 (Pubitemid 350089986)
34. Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, Leischow S (2005) Methods to assess potential reduced exposure products. Nicotine Tob Res 7:827-844 (Pubitemid 43101701)
35. Hatsukami DK, Perkins KA, Lesage MG, Ashley DL, Henningfield JE, Benowitz NL, Backinger CL, Zeller M (2010) Nicotine reduction revisited: science and future directions. Tob Control 19: e1-e10
36. Hecht SS, Carmella S, Mori H, Hoffmann D (1981) A study of tobacco carcinogenesis. XX. Role of catechol as a major cocarcinogen in the weakly acidic fraction of smoke condensate. J Natl Canc Inst 66:163-169 (Pubitemid 11163250)
37. Hieda Y, Keyler DE, VanDeVoort JT, Niedbala RS, Raphael DE, Ross CA, Pentel PR (1999) Immunization of rats reduces nicotine distribution to brain. Psychopharmacology (Berl) 143:150-157 (Pubitemid 29187639)
38. Huston-Lyons D, Kornetsky C (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 41:755-759
39. Jacob P 3rd, Wilson M, Benowitz NL (1981) Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr 222:61-70 (Pubitemid 11141159)
40. Jacob P 3rd, Yu L, Liang G, Shulgin AT, Benowitz NL (1993) Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users. J Chromatogr 619:49-61 (Pubitemid 23282006)
41. Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG (2009) Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Canc Epidemiol Biomarkers Prev 18:3263-3304
42. Keyler DE, Roiko SA, Benlhabib E, Lesage MG, St Peter JV, Stewart S, Fuller S, Le CT, Pentel PR (2005) Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships. Drug Metabol Dispos 33:1056-1061 (Pubitemid 41002789)
43. Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38:2473-2476 (Pubitemid 10249276)
44. Laviolette SR, van der Kooy D (2003) Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatr 8(50-59):9
45. LeSage MG, Shelley D, Ross JT, Carroll FI, Corrigall WA (2009) Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. Pharmacol Biochem Behav 91:461-467
46. MacInnes N, Handley SL (2002) Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine. Br J Pharmacol 135:1227-1234 (Pubitemid 34259125)
47. Markou A, Koob GF (1992) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51:111-119
48. Murray JE, Bevins RA (2007a) Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus. Eur J Pharmacol 561:91-104 (Pubitemid 46435861)
49. Murray JE, Bevins RA (2007b) The conditional stimulus effects of nicotine vary as a function of training dose. Behav Pharmacol 18:707-716 (Pubitemid 350076427)
50. Pappas RS, Stanfill SB, Watson CH, Ashley DL (2008) Analysis of toxic metals in commercial moist snuff and Alaskan iqmik. J Anal Toxicol 32:281-291 (Pubitemid 351679818)
51. Pederson LL, Nelson DE (2007) Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications. Nicotine Tob Res 9:525-534 (Pubitemid 46672431)
52. Pentel PR, Dufek MB, Roiko SA, Lesage MG, Keyler DE (2006) Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats. J Pharmacol Exp Ther 317:660-666
53. Philibin SD, Vann RE, Varvel SA, Covington HE 3rd, Rosecrans JA, James JR, Robinson SE (2005) Differential behavioral responses to nicotine in Lewis and Fischer-344 rats. Pharmacol Biochem Behav 80:87-92 (Pubitemid 40126206)
54. Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology (Berl) 81:54-60 (Pubitemid 13038262)
55. Rodriguez D, Audrain-McGovern J (2004) Construct validity analysis of the early smoking experience questionnaire for adolescents. Addict Behav 29:1053-1057 (Pubitemid 38822968)
56. Roiko SA, Harris AC, Keyler DE, Lesage MG, Zhang Y, Pentel PR (2008) Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. J Pharmacol Exp Ther 325:985-993 (Pubitemid 351724343)
57. Roiko SA, Harris AC, LeSage MG, Keyler DE, Pentel PR (2009) Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats. Pharmacol Biochem Behav 93:105-111
58. Sellings LH, Baharnouri G, McQuade LE, Clarke PB (2008) Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens. Eur J Neurosci 28:342-352
59. Skott M, Andreassen TT, Ulrich-Vinther M, Chen X, Keyler DE, LeSage MG, Pentel PR, Bechtold JE, Soballe K (2006) Tobacco extract but not nicotine impairs the mechanical strength of fracture healing in rats. J Orthop Res 24:1472-1479 (Pubitemid 44083263)
60. Smith JW, Stolerman IP (2009) Recognising nicotine: the neurobio-logical basis of nicotine discrimination. Handb Exp Pharmacol: 295-333
61. Spiller K, Xi ZX, Li X, Ashby CR Jr, Callahan PM, Tehim A, Gardner EL (2009) Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats. Neuropharmacology 57:60-66
62. Stepanov I, Hecht SS, Ramakrishnan S, Gupta PC (2005) Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int J Canc 116:16-19 (Pubitemid 40827750)
63. Stepanov I, Jensen J, Hatsukami D, Hecht SS (2008) New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 10:1773-1782
64. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology (Berl) 84:413-419 (Pubitemid 15205971)
65. Stolerman IP, Rauch RJ, Norris EA (1987) Discriminative stimulus effects of a nicotine-midazolam mixture in rats. Psychopharma-cology (Berl) 93:250-256 (Pubitemid 18013066)
66. Stolerman IP, White JA (1996) Impact of training history on discrimination of a drug mixture by rats. Behav Pharmacol 7:483-494 (Pubitemid 26365136)
67. Touiki K, Rat P, Molimard R, Chait A, de Beaurepaire R (2007) Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. Neuroreport 18:925-929 (Pubitemid 46791526)
68. U.S. Department of Health and Human Services (1999) Nicotine addiction: health consequences of smoking. DHHS
69. Urban R (2010) Early smoking experience in adolescents. Addict Behav 35:612-615
70. Vezina P, McGehee DS, Green WN (2007) Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsycho-pharmacol Biol Psychiatry 31:1625-1638 (Pubitemid 47625708)
71. Villegier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM (2007) Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52:1415-1425 (Pubitemid 46601533)
72. Wilmouth CE, Spear LP (2004) Adolescent and adult rats' aversion to flavors previously paired with nicotine. Ann N Y Acad Sci 1021:462-464 (Pubitemid 38879666)
73. Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229-240 (Pubitemid 35217889)
74. Wooters TE, Bevins RA, Bardo MT (2009) Neuropharmacology of the interoceptive stimulus properties of nicotine. Curr Drug Abuse Rev 2:243-255
75. York JL (1981) The ethanol stimulus in rats with differing ethanol preferences. Psychopharmacology (Berl) 74:339-343 (Pubitemid 11003753)
76. Zaniewska M, McCreary AC, Stefanski R, Przegalinski E, Filip M (2008) Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats. Synapse 62:935-939
77. Zeller M, Hatsukami D (2009) The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tob Control 18:324-332
78. Zhang W, Kilicarslan T, Tyndale RF, Sellers EM (2001) Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metabol Dispos 29:897-902 (Pubitemid 32488648)
79. Zubaran C, Shoaib M, Stolerman IP (2000) The development and expression of locomotor sensitization to nicotine in the presence of ibogaine. Behav Pharmacol 11:431-436 (Pubitemid 30663893)